News

Dr. Tshaka Cunningham, Associate Director of Scientific Collaboration for DIA, will discuss his perspectives on advancements in gene editing therapies and their impact on the industry.

Updated employee announcements, business news, awards, and recognition in the industry today.

Advances in our understanding of the genetic, immunological, and environmental factors that contribute to the pathogenesis of psoriasis have led to the development of very effective precision therapies that alleviate patient morbidity and improve quality of life, especially for patients with moderate to severe disease.

The results of a 2018 survey of sponsor, CRO, and technology companies.

Cell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.